In animal studies, BPC-157 has shown protective effects in central nervous system injury models and nasal peptide delivery can allow compounds to reach brain tissues, so scientists are exploring whether it may help reduce nerve inflammation and support recovery after injury
Conflict of interest JT has given Scientific advice to AlfaWassermann, Allergan, Christian Hansen, Danone, Grnenthal, Ironwood, Janssen, Kiowa Kirin, Menarini, Mylan, Neutec, Novartis, Noventure, Nutricia, Shionogi, Shire, Takeda, Theravance, Tramedico, Truvion, Tsumura, Zealand, and Zeria pharmaceuticals and has served on the Speaker bureau for Abbott, Allergan, AstraZeneca, Janssen, Kyowa Kirin, Menarini, Mylan, Novartis, Shire, Takeda, Truvion, and Zeria
En la pasta, las manzanas, el brcoli o las patatas, la proporcin es casi insignificante
For subcutaneous human use in the research-compound context, practitioners typically report timelines similar to topical: noticeable changes from 4 weeks, more pronounced at 8 to 12 weeks
